Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression

被引:157
作者
Dirksen, U
Nishinakamura, R
Groneck, P
Hattenhorst, U
Nogee, L
Murray, R
Burdach, S
机构
[1] UNIV DUSSELDORF,CHILDRENS HOSP,MED CTR,DEPT PEDIAT,D-40225 DUSSELDORF,GERMANY
[2] UNIV DUSSELDORF,BIOMED RES CTR,BMFZ,D-40225 DUSSELDORF,GERMANY
[3] DNAX RES INST MOL & CELLULAR BIOL INC,PALO ALTO,CA 94304
[4] CHILDRENS HOSP,DIV NEONATOL,D-50735 COLOGNE,GERMANY
[5] JOHNS HOPKINS UNIV,SCH MED,EUDOWOOD NEONATAL PULM DIV,BALTIMORE,MD 21287
关键词
pulmonary alveolar proteinosis; GM-CSF/IL-3/IL-5; receptor; common beta chain; alveolar macrophages; surfactant;
D O I
10.1172/JCI119758
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pulmonary alveolar proteinosis (PAP) is a heterogenous disorder of genetic or acquired etiologies. In some cases congenital PAP is associated with hereditary surfactant protein (SP)-B deficiency. To date, the molecular defect in the majority of patients with PAP has not been identified. In mice, PAP has been generated by targeted deletion of the genes for either the GM-CSF/IL3/IL-5 receptor common beta chain (beta c) or GM-CSF. Here, we describe an expression defect of beta c in three of seven pediatric patients with PAP and in one patient with severe lung disease suspected to be PAP. The patients failed to express normal levels of beta c as shown by now cytometry. Strikingly reduced or absent function of beta c was demonstrated by ligand binding studies and progenitor clonogenic assays. Analysis of beta c DNA revealed a point mutation from proline to threonine at codon 602 in one patient. Our findings provide evidence that a defect in the expression of a hematopoietic cytokine receptor is associated with human PAP.
引用
收藏
页码:2211 / 2217
页数:7
相关论文
共 30 条
[1]  
AYMARD JP, 1984, CANCER-AM CANCER SOC, V53, P954, DOI 10.1002/1097-0142(19840215)53:4<954::AID-CNCR2820530422>3.0.CO
[2]  
2-Q
[3]   DIFFERENTIAL REGULATION OF LYMPHOKINE PRODUCTION BY DISTINCT SUBUNITS OF THE T-CELL INTERLEUKIN-2 RECEPTOR [J].
BURDACH, S ;
ZESSACK, N ;
DILLOO, D ;
SHATSKY, M ;
THOMPSON, D ;
LEVITT, L .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2114-2121
[4]  
Callard RE, 1994, CYTOKINE FACTS BOOK
[5]   MOLECULAR AND PHENOTYPIC VARIABILITY IN THE CONGENITAL ALVEOLAR PROTEINOSIS SYNDROME-ASSOCIATED WITH INHERITED SURFACTANT PROTEIN-B DEFICIENCY [J].
DEMELLO, DE ;
NOGEE, LM ;
HEYMAN, S ;
KROUS, HF ;
HUSSAIN, M ;
MERRITT, A ;
HSUEH, W ;
HAAS, JE ;
HEIDELBERGER, K ;
SCHUMACHER, R ;
COLTEN, HR .
JOURNAL OF PEDIATRICS, 1994, 125 (01) :43-50
[6]  
Dilloo D, 1996, EXP HEMATOL, V24, P537
[7]  
Dirksen Uta, 1996, Blood, V88, p660A
[8]   INVOLVEMENT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PULMONARY HOMEOSTASIS [J].
DRANOFF, G ;
CRAWFORD, AD ;
SADELAIN, M ;
REAM, B ;
RASHID, A ;
BRONSON, RT ;
DICKERSIN, GR ;
BACHURSKI, CJ ;
MARK, EL ;
WHITSETT, JA ;
MULLIGAN, RC .
SCIENCE, 1994, 264 (5159) :713-716
[9]   DEFECTIVE LUNG MACROPHAGES IN PULMONARY ALVEOLAR PROTEINOSIS [J].
GOLDE, DW ;
TERRITO, M ;
FINLEY, TN ;
CLINE, MJ .
ANNALS OF INTERNAL MEDICINE, 1976, 85 (03) :304-309
[10]  
GREEN D, 1980, CANCER, V46, P1763, DOI 10.1002/1097-0142(19801015)46:8<1763::AID-CNCR2820460811>3.0.CO